Cargando…
Cost-minimization analysis of immunoglobulin treatment of primary immunodeficiency diseases in Spain
Primary immunodeficiency diseases (PID), which are comprised of over 400 genetic disorders, occur when a component of the immune system is diminished or dysfunctional. Patients with PID who require immunoglobulin (IG) replacement therapy receive intravenous IG (IVIG) or subcutaneous IG (SCIG), each...
Autores principales: | Alsina, Laia, Montoro, J. Bruno, Moral, Pedro Moral, Neth, Olaf, Pica, Marta Ortiz, Sánchez-Ramón, Silvia, Presa, María, Oyagüez, Itziar, Casado, Miguel Ángel, González-Granado, Luis Ignacio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8964571/ https://www.ncbi.nlm.nih.gov/pubmed/34546485 http://dx.doi.org/10.1007/s10198-021-01378-x |
Ejemplares similares
-
Cost-effectiveness analysis of treatment sequences containing tofacitinib for the treatment of rheumatoid arthritis in Spain
por: Navarro, F., et al.
Publicado: (2020) -
Epidemiologic and Economic Analysis of Rapid Antiretroviral Therapy Initiation with Bictegravir/Emtricitabine/Tenofovir Alafenamide in Spain
por: Estrada, Vicente, et al.
Publicado: (2022) -
Budgetary impact analysis of buprenorphine-naloxone combination (Suboxone(®)) in Spain
por: Martinez-Raga, Jose, et al.
Publicado: (2012) -
Use of Floseal(®), a human gelatine-thrombin matrix sealant, in surgery: a systematic review
por: Echave, María, et al.
Publicado: (2014) -
Prophylaxis therapy with bypassing agents in patients with haemophilia A and inhibitors undergoing surgery: A cost analysis in Spain
por: Mareque, María, et al.
Publicado: (2020)